Development and Characterization of A Recombinant Truncated Type VII Collagen “Minigene” IMPLICATION FOR GENE THERAPY OF DYSTROPHIC EPIDERMOLYSIS BULLOSA*

Overview of attention for article published in Journal of Biological Chemistry, August 2000

Altmetric Badge

Mentioned by

patent: 24 patents

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 24 patents that reference this research output.

Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected…

Grant US-12559717-B2

United States of America

24 Feb 2026

Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected…

Grant US-12385010-B2

United States of America

12 Aug 2025

Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected…

Grant US-12173314-B2

United States of America

24 Dec 2024

Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected…

Grant US-12110504-B2

United States of America

08 Oct 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 20 additional patents.